Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Teva
McKinsey
Queensland Health
Baxter
Novartis
Covington
Johnson and Johnson
Merck

Generated: October 17, 2017

DrugPatentWatch Database Preview

Abbott Company Profile

« Back to Dashboard

What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?

ABBOTT has one hundred and thirteen approved drugs.



Summary for Applicant: Abbott

US Patents:0
Tradenames:91
Ingredients:64
NDAs:113
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
NITROPRESS
sodium nitroprusside
INJECTABLE;INJECTION071555-001Nov 16, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
INJECTABLE;INJECTION084223-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-001Dec 14, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbott
BRETYLIUM TOSYLATE IN DEXTROSE 5%
bretylium tosylate
INJECTABLE;INJECTION019005-003Apr 29, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
oxytocin
INJECTABLE;INJECTION019185-003Mar 29, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbott
ERYTHROCIN
erythromycin lactobionate
INJECTABLE;INJECTION062586-001Jan 4, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
A-HYDROCORT
hydrocortisone sodium succinate
INJECTABLE;INJECTION089578-001Apr 11, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
TETRACYCLINE HYDROCHLORIDE
tetracycline hydrochloride
CAPSULE;ORAL061802-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
AMMONIUM CHLORIDE
ammonium chloride
INJECTABLE;INJECTION083130-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
CHLORPROMAZINE HYDROCHLORIDE
chlorpromazine hydrochloride
TABLET;ORAL084412-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Abbott

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
NORVIR
ritonavir
CAPSULE;ORAL020680-001Mar 1, 1996► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-004Dec 14, 1994► Subscribe► Subscribe
Abbott
NORVIR
ritonavir
CAPSULE;ORAL020680-001Mar 1, 1996► Subscribe► Subscribe
Abbott
MERIDIA
sibutramine hydrochloride
CAPSULE;ORAL020632-002Nov 22, 1997► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-004Dec 14, 1994► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-002Dec 14, 1994► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-001Dec 14, 1994► Subscribe► Subscribe
Abbott
NORVIR
ritonavir
CAPSULE;ORAL020680-001Mar 1, 1996► Subscribe► Subscribe
Abbott
DEPAKOTE CP
divalproex sodium
TABLET, DELAYED RELEASE;ORAL019794-002Jul 11, 1990► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-001Dec 14, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ABBOTT drugs

Drugname Dosage Strength Tradename Submissiondate
ritonavir
Capsules100 mg
NORVIR
10/31/2012
ritonavir
Tablets100 mg
NORVIR
12/21/2010
sibutramine hydrochloride
Capsules10 mg and 15 mg
MERIDIA
8/14/2009

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
UBS
Accenture
Citi
Moodys
Chubb
Boehringer Ingelheim
Julphar
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot